THE PATHOGENESIS AND PATHOLOGY OF EXPERIMENTAL TYPE I PNEUMOCOCCIC PNEUMONIA IN THE MONKEY

C G Loosli1

  • 1Department of Medicine and the Douglas Smith Foundation for Medical Research of The University of Chicago, Chicago.

Insights

This study details how pneumococcic pneumonia causes lung consolidation, primarily through air space inflammation and spread via infected fluid. It clarifies the roles of different cells in the inflammatory response.

Area of Science:

  • Pathology
  • Microbiology
  • Immunology

Background:

  • Lobar consolidation is a key feature of pneumococcal pneumonia.
  • Understanding the precise mechanisms of pneumonia pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the pathogenesis and microscopic pathology of induced Type I pneumococcic pneumonia in monkeys.
  • To elucidate the spread of pneumococci and the inflammatory cell responses within the lung.

Main Methods:

  • Experimental induction of Type I pneumococcic pneumonia in fourteen monkeys.
  • Microscopic examination of lung tissue at frequent intervals post-infection.
  • Analysis of inflammatory cell origins and transformations.

Main Results:

  • Consolidation resulted from intra-alveolar and intra-bronchial inflammation, with pneumococci spreading through air spaces.
  • Interstitial spread of organisms was secondary to alveolar infection and a source of bacteremia, not consolidation.
  • Exudate cells, particularly macrophages, were primarily derived from blood monocytes and lymphocytes, with a limited role for local septal cells.

Conclusions:

  • The pathogenesis of lobar consolidation in experimentally induced pneumonia mirrors that in human cases.
  • The inflammatory process and cellular dynamics in pneumococcal pneumonia are complex, involving distinct pathways for consolidation and bacteremia.
  • Further detailed examination of early inflammatory responses is needed to fully understand macrophage transformation.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation